Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome

Molecular Medicine

Volumn 15, Issue 1-2, 2009, Pages 34-42

  Sorensen, Bristol ^a,c   Jones, James F ^a   Vernon, Suzanne D ^a,d   Rajeevan, Mangalathu S ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d CFIDS Association of America   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4A; FICOLIN; ISOMERASE; LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNOSE BINDING LECTIN 2; PEPTIDYLPROPYL ISOMERASE B; PHOSPHOGLYCERATE KINASE; RIBOSOME PROTEIN; RIBULOSEBISPHOSPHATE CARBOXYLASE; UNCLASSIFIED DRUG; COMPLEMENT COMPONENT C4; MASP2 PROTEIN, HUMAN;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; EXERCISE; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GEOMETRY; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; REPRODUCIBILITY;

ADULT; COMPLEMENT ACTIVATION; COMPLEMENT C4; EXERCISE; FATIGUE SYNDROME, CHRONIC; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; REPRODUCIBILITY OF RESULTS; TRANSCRIPTION, GENETIC;

EID: 59649095580     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2008.00098     Document Type: Article

References (56)

1. Fukuda K, et al. (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 121:953-59.
2. Reeves WC, et al. (2005) Chronic fatigue syndrome - a clinically empirical approach to its definition and study. BMC. Med. 3:19.
3. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. (2005) Exercise treatment for depression: efficacy and dose response. Am. J. Prev. Med. 28:1-8.
4. Bearne LM, Scott DL, Hurley MV. (2002) Exercise can reverse quadriceps sensorimotor dysfunction that is associated with rheumatoid arthritis without exacerbating disease activity. Rheumatology (Oxford) 41:157-66.
5. Robb-Nicholson LC, et al. (1989) Effects of aerobic conditioning in lupus fatigue: a pilot study. Br. J. Rheumatol. 28:500-5.
6. Mostert S, Kesselring J. (2002) Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult. Scler. 8:161-8.
7. Wagner D, et al. (2005) Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul. Health Metr. 3:8.
8. Vollmer-Conna U, Aslakson E, White PD. (2006) An empirical delineation of the heterogeneity of chronic unexplained fatigue in women. Pharmacogenomics 7:355-64.
9. Sorensen B, et al. (2003) Complement activation in a model of chronic fatigue syndrome. J. Allergy Clin. Immunol. 112:397-403.
10. Whistler T, Jones JF, Unger ER, Vernon SD. (2005) Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC. Physiol. 5:5.
11. Gulati P, Lemercier C, Guc D, Lappin D, Whaley K. (1993) Regulation of the synthesis of C1 subcomponents and C1-inhibitor. Behring Inst. Mitt. 196-203.
12. Kolosov M, Kolosova I, Zhou A, Leu RW. (1996) Autocrine induction of macrophage synthesis of complement subcomponent C1q by endogenous interferon-alpha/beta. J. Interferon Cytokine Res. 16:209-15.
13. Walker DG. (1998) Expression and regulation of complement C1q by human THP-1-derived macrophages. Mol. Chem. Neuropathol. 34:197-218.
14. Drouet C, Reboul A. (1989) Biosynthesis of C1r and C1s subcomponents. Behring Inst. Mitt. 84:80-8.
15. Collins T, Winkelstein JA, Sullivan KE. (1996) Regulation of early complement components C3 and C4 in the synovium. Clin. Diagn. Lab. Immunol. 3:5-9.
16. Kulics J, Circolo A, Strunk RC, Colten HR. (1994) Regulation of synthesis of complement protein C4 in human fibroblasts: cell- and gene-specific effects of cytokines and lipopolysaccharide. Immunology 82:509-15.
17. Sacks S, Zhou W, Campbell RD, Martin J. (1993) C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells. Clin. Exp. Immunol. 93:411-7.
18. Seelen MA, Brooimans RA, van der Woude FJ, van Es LA, Daha MR. (1993) IFN-gamma mediates stimulation of complement C4 biosynthesis in human proximal tubular epithelial cells. Kidney Int. 44:50-7.
19. Vincent F, et al. (1993) Synthesis and regulation of complement components by human monocytes/macrophages and by acute monocytic leukemia. DNA Cell Biol. 12:415-23.
20. Zimmermann-Nielsen E, Svehag SE, Thorlacius-Ussing O, Baatrup G. (2001) ELISA for evaluating the incorporation of plasma derived complement split-products C3b/iC3b into solid-phase immune complexes. J. Immunol. Methods 249:43-51
21. Huang Z, Fasco MJ, Kaminsky LS. (1996) Optimization of Dnase I removal of contaminating DNA from RNA for use in quantitative RNA-PCR. Biotechniques 20:1012-20.
22. Rajeevan MS, Ranamukhaarachchi DG, Vernon SD, Unger ER. (2001) Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods 25:443-51.
23. Skrzypski M. (2008) Quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR) in translational oncology: lung cancer perspective. Lung Cancer 59:147-54.
24. Pachot A, Blond JL, Mougin B, Miossec P. (2004) Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood. J. Biotechnol. 114:121-4.
25. Bower NI, Moser RJ, Hill JR, Lehnert SA. (2007) Universal reference method for real-time PCR gene expression analysis of preimplantation embryos. Biotechniques 42:199-206.
26. Gilsbach R, Kouta M, Bonisch H, Bruss M. (2006) Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. Biotechniques 40:173-7.
27. Vandesompele J, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:research0034.1-11.
28. Seyfarth J, Garred P, Madsen HO. (2006) Extrahepatic transcription of the human mannosebinding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes. Mol. Immunol. 43:962-71.
29. Fan Q, Weill B, Delpech M. (1994) Study of C4A mRNA in mononuclear blood cells from a patient with SLE and C4A homozygous deficiency without C4A gene deletion. Clin. Exp. Rheumatol. 12:657-60.
30. Lu J, Le Y, Kon OL, Chan J, Lee SH. (1996) Biosynthesis of human ficolin, an Escherichia coli-binding protein, by monocytes: comparison with the synthesis of two macrophage-specific proteins, C1q and the mannose receptor. Immunology 89:289-94.
31. Moosig F, et al. (2006) Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 146:409-16.
32. Endo Y, Matsushita M, Fujita T. (2007) Role of ficolin in innate immunity and its molecular basis. Immunobiology 212:371-9.
33. Honore C, et al. (2008) The innate pattern recognition molecule Ficolin-1 is secreted by monocytes/macrophages and is circulating in human plasma. Mol. Immunol. 45:2782-9.
34. Watt MJ, Heigenhauser GJ, Dyck DJ, Spriet LL. (2002) Intramuscular triacylglycerol, glycogen and acetyl group metabolism during 4 h of moderate exercise in man. J. Physiol. 541:969-78.
35. White LJ, et al. (2006) Accumulation of acetyl groups following cycling: a 1H-MR spectroscopy study. Int. J. Sports Med. 27:100-4.
36. Dufaux B, Order U. (1989) Complement activation after prolonged exercise. Clin. Chim. Acta. 179:45-9.
37. Markiewski MM, Lambris JD. (2007) The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 171:715-27.
38. Shek PN, Shephard RJ. (1998) Physical exercise as a human model of limited inflammatory response. Can. J. Physiol. Pharmacol. 76:589-97.
39. Nancy AL, Shoenfeld Y. (2008) Chronic fatigue syndrome with autoantibodies: the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmun. Rev. 8:52-5.
40. Tsuruta T, et al. (1993) Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis. Am. J. Pathol. 142:1848-57.
41. Erdei A, Andrasfalvy M, Peterfy H, Toth G, Pecht I. (2004) Regulation of mast cell activation by complement-derived peptides. Immunol. Lett. 92:39-42.
42. Endo Y, et al. (2002) Functional characterization of human mannose-binding lectin-associated serine protease (MASP)-1/3 and MASP-2 promoters, and comparison with the C1s promoter. Int. Immunol. 14:1193-201.
43. Unterberger C, et al. (2007) Stat3 is involved in control of MASP2 gene expression. Biochem. Biophys. Res. Commun. 364:1022-5.
44. Baschetti R. (2005) Chronic fatigue syndrome, exercise, cortisol and lymphadenopathy. J. Intern. Med. 258:291-2.
45. Glass JM, et al. (2004) The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. J. Psychosom. Res. 57:391-8.
46. Van Den EF, Moorkens G, Van HB, Cosyns P, Claes SJ. (2007) Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. Neuropsychobiology 55:112-20.
47. Ernst E, Espersen GT, Andersen MV. (1990) Reduction of complement activation in rheumatoid arthritis by steroid treatment. Int. J. Tissue React. 12:77-9.
48. Packard BD, Weiler JM. (1983) Steroids inhibit activation of the alternative-amplification pathway of complement. Infect. Immun. 40:1011-4.
49. Zimmermann-Nielsen E, Gronbaek H, Dahlerup JF, Baatrup G, Thorlacius-Ussing O. (2005) Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn?s disease and ulcerative colitis. BMC. Gastroenterol. 5:31.
50. Li TL, Cheng PY. (2007) Alterations of immunoendocrine responses during the recovery period after acute prolonged cycling. Eur. J. Appl. Physiol. 101:539-46.
51. Minetto MA, et al. (2007) Corticotroph axis sensitivity after exercise: comparison between elite athletes and sedentary subjects. J. Endocrinol. Invest. 30:215-23.
52. Rojas VS, et al. (2006) Acute BDNF and cortisol response to low intensity exercise and following ramp incremental exercise to exhaustion in humans. Brain Res. 1121:59-65.
53. Minetto MA, et al. (2008) Changes in awakening cortisol response and midnight salivary cortisol are sensitive markers of strenuous training-induced fatigue. J. Endocrinol. Invest. 31:16-24.
54. Leal-Cerro A, et al. (2003) Mechanisms underlying the neuroendocrine response to physical exercise. J. Endocrinol. Invest. 26:879-85.
55. Dishman RK, et al. (2006) Neurobiology of exercise. Obesity (Silver Spring) 14:345-56.
56. Lorusso L, et al. (2008) Immunological aspects of chronic fatigue syndrome. Autoimmun. Rev. 2008, Sep 15. [Epub ahead of print].